<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2022-1-14-19</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1246</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Систематический обзор и метаанализ: факторы риска развития псориатического артрита. Часть 1.</article-title><trans-title-group xml:lang="en"><trans-title>Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 1.</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1563-9475</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Переверзина</surname><given-names>Н. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Pereverzina</surname><given-names>N. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Олеговна Переверзина</p><p>121359, Москва, ул. Маршала Тимошенко</p></bio><bio xml:lang="en"><p>Natalia Olegovna Pereverzina</p><p>119, Marshala Timoshenko street, building 1A, Moscow 121359</p></bio><email xlink:type="simple">natalia.pereverzina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5044-5265</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Круглова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kruglova</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>121359, Москва, ул. Маршала Тимошенко, 19, стр. 1А</p></bio><bio xml:lang="en"><p>19, Marshala Timoshenko street, building 1A, Moscow 121359</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0579-1131</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коротаева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Korotaeva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лила</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lila</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p><p>125993, Москва, ул. Баррикадная, 2/1, стр. 1</p></bio><bio xml:lang="en"><p>34A, Kashirskoe shosse, Moscow 115522</p><p>2/1, Barrikadnaya street, building 1, Moscow 125993</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательскии институт ревматологии им. В.А.  Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательскии институт ревматологии им. В.А. Насоновой»; кафедра ревматологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology, Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>17</day><month>02</month><year>2022</year></pub-date><volume>16</volume><issue>1</issue><fpage>14</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Переверзина Н.О., Круглова Л.С., Коротаева Т.В., Лила А.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Переверзина Н.О., Круглова Л.С., Коротаева Т.В., Лила А.М.</copyright-holder><copyright-holder xml:lang="en">Pereverzina N.O., Kruglova L.S., Korotaeva T.V., Lila A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1246">https://mrj.ima-press.net/mrj/article/view/1246</self-uri><abstract><p>По данным эпидемиологических и клинических исследовании, у каждого четвертого пациента с псориазом развивается псориатическии артрит (ПсА), причем во многих случаях наблюдается деструктивная форма артрита, приводящая к инвалидности. Поздняя диагностика ПсА ассоциируется с существенным снижением эффективности терапии. Поэтому так важно раннее выявление данного заболевания.Цель систематического обзора и метаанализа – определение способов раннего выявления ПсА, в частности установление факторов риска (ФР) его развития, что позволит предотвращать прогрессирование заболевания и инвалидизацию пациентов.Материалы и методы. Обзор литературы и метаанализ представлен в двух частях. В часть 1 систематического обзора вошли статьи об экзогенных факторах риска (ФР) развития ПсА, опубликованные за последние 10 лет. В базах данных PubMed (MEDLINE), EMBASE и Google Scholar проведен поиск статей, опубликованных до 1 марта 2021 г. Поиск текущих зарегистрированных исследований осуществлялся в реестрах клинических исследований США (ClinicalТrials.gov), Китая (Chinese Clinical Trial Registry) и на Международной платформе регистрации клинических исследований ВОЗ (WHO International Clinical Trial Registry Platform). Статистический анализ был подготовлен в соответствии с международными рекомендациями для систематических обзоров и метаанализа (PRISMA) при помощи программы Statistic SPSS 26.0 (США).Результаты и обсуждение. Идентифицировано 957 статей, опубликованных до 1 марта 2021 г. После дальнейшего анализа были исключены нерелевантные статьи. Всего в обзор и анализ вошли 73 статьи, из них 32 – в часть 1. Наиболее распространенными экзогенными ФР являются: механические травмы, прием лекарственных препаратов и психотравмирующие ситуации.Заключение. ПсА является многофакторным заболеванием. В настоящее время установлено большое число экзогенных ФР развития данного заболевания. Знание ФР и умение их распознавать помогут дерматовенерологам и ревматологам эффективно оценивать и прогнозировать состояние пациента. Коррекция модифицируемых ФР, раннее назначение соответствующей терапии будут способствовать уменьшению числа случаев ПсА, развития функциональных расстройств и предотвращению роста инвалидизации. Тем не менее исследований, посвященных комплексной оценке ФР при ПсА, все еще недостаточно. Необходимо дальнейшее изучение способов ранней диагностики ПсА с целью оптимизации его лечения.</p></abstract><trans-abstract xml:lang="en"><p>According to epidemiological and clinical studies, every fourth patient with psoriasis develops psoriatic arthritis (PsA), and in many cases there is a destructive form of arthritis that leads to disability. Late diagnosis of PsA is associated with a significant reduction in the effectiveness of therapy. Therefore, early diagnosis of this disease is so important.Objective: to determine the methods for early detection of PsA, in particular the identification of risk factors (RFs) for its development, which will prevent the progression of the disease and the disability of patients.Materials and methods. The literature review and meta-analysis is presented in two parts. Part 1 of the systematic review included articles on exogenous RFs for the development of PsA published over the past 10 years.PubMed (MEDLINE), EMBASE, and Google Scholar databases were searched for articles published before March 1, 2021. We searched for currently registered trials in the registers of clinical trials of US (ClinicalTrials.gov), of China (Chinese Clinical Trial Registry) and the WHO InternationalClinical Trial Registry Platform. The statistical analysis was prepared in accordance with the international guidelines for systematic reviews and meta-analysis (PRISMA) using the Statistic SPSS 26.0 program (USA).Results and discussion. 957 articles published up to March 1, 2021 were identified. After further analysis, irrelevant articles were excluded. A total of 73 articles were included in the review and analysis, 32 of which were included in Part 1. The most common exogenous RFs are: mechanical injuries, medications, and psychotraumatic situations.Conclusion. PsA is a multifactorial disease. Currently, a large number of exogenous RFs for the development of this disease have been established. Knowledge of RFs and the ability to recognize them will help dermatovenereologists and rheumatologists to effectively assess and predict the patient's condition. Correction of modifiable RFs, early prescription of appropriate therapy will help to reduce the number of PsA cases, the development of functional disorders and prevent the growth of disability. However, studies on the comprehensive assessment of RFs in PsA are still insufficient. Further study of methods for the early diagnosis of PsA is needed in order to optimize its treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>псориаз</kwd><kwd>псориатический артрит</kwd><kwd>предикторы</kwd><kwd>факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>psoriasis</kwd><kwd>psoriatic arthritis</kwd><kwd>predictors</kwd><kwd>risk factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Boehncke WH, Schцn MP. Psoriasis. Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7.</mixed-citation><mixed-citation xml:lang="en">Boehncke WH, Schцn MP. Psoriasis. Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chimenti MS, Caso F, Alivernini S, et al. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease. Autoimmun Rev. 2019 Jun;18(6):565-75. doi: 10.1016/j.autrev.2018.11.007.</mixed-citation><mixed-citation xml:lang="en">Chimenti MS, Caso F, Alivernini S, et al. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease. Autoimmun Rev. 2019 Jun;18(6):565-75. doi: 10.1016/j.autrev.2018.11.007.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018 Jun 2; 391(10136):2273-84. doi: 10.1016/S0140-6736(18)30830-4.</mixed-citation><mixed-citation xml:lang="en">Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018 Jun 2; 391(10136):2273-84. doi: 10.1016/S0140-6736(18)30830-4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and metaanalysis of observational and clinical studies. J Am Acad Dermatol. 2019 Jan;80(1): 251-65.e19. doi: 10.1016/j.jaad.2018.06.027.</mixed-citation><mixed-citation xml:lang="en">Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and metaanalysis of observational and clinical studies. J Am Acad Dermatol. 2019 Jan;80(1): 251-65.e19. doi: 10.1016/j.jaad.2018.06.027.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Коротаева ТВ, Корсакова ЮЛ, Логинова ЕЮ и др. Псориатический артрит. Клинические рекомендации по диагностике и лечению. Современная ревматология. 2018;12(2):22-35.</mixed-citation><mixed-citation xml:lang="en">Korotaeva TV, Korsakova YuL, Loginova EY, et al. Psoriatic arthritis. Clinical guidelines for diagnosis and treatment. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2018;12(2):22-35. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tillett W, Charlton R, Nightingale A, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017 Dec 1; 56(12):2109-13. doi: 10.1093/rheumatology/kex323.</mixed-citation><mixed-citation xml:lang="en">Tillett W, Charlton R, Nightingale A, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017 Dec 1; 56(12):2109-13. doi: 10.1093/rheumatology/kex323.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015 Jun;74(6):1045-50. doi: 10.1136/annrheumdis-2013-204858.</mixed-citation><mixed-citation xml:lang="en">Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015 Jun;74(6):1045-50. doi: 10.1136/annrheumdis-2013-204858.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Burgers LE, Raza K, van der Helm, van Mil AH. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives. RMD Open. 2019 Apr 3;5(1):e000870. doi: 10.1136/rmdopen-2018-000870.eCollection 2019.</mixed-citation><mixed-citation xml:lang="en">Burgers LE, Raza K, van der Helm, van Mil AH. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives. RMD Open. 2019 Apr 3;5(1):e000870. doi: 10.1136/rmdopen-2018-000870.eCollection 2019.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Van Steenbergen HW, da Silva JAP, Huizinga TWJ, et al. Preventing progression from arthralgia to arthritis: targeting the right patients. Nat Rev Rheumatol. 2018 Jan;14(1): 32-41. doi: 10.1038/nrrheum.2017.185.</mixed-citation><mixed-citation xml:lang="en">Van Steenbergen HW, da Silva JAP, Huizinga TWJ, et al. Preventing progression from arthralgia to arthritis: targeting the right patients. Nat Rev Rheumatol. 2018 Jan;14(1): 32-41. doi: 10.1038/nrrheum.2017.185.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">https://www.who.int/topics/risk_factors/ru/</mixed-citation><mixed-citation xml:lang="en">https://www.who.int/topics/risk_factors/ru/</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Scarpa R, Del Puente A, di Girolamo C, et al. Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis. 1992 Jan;51(1):78-9. doi: 10.1136/ard.51.1.78.</mixed-citation><mixed-citation xml:lang="en">Scarpa R, Del Puente A, di Girolamo C, et al. Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis. 1992 Jan;51(1):78-9. doi: 10.1136/ard.51.1.78.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">De Vlam K, Gottlieb AB, Mease PJ. Current concepts in psoriatic arthritis: pathogenesis and management. Acta Derm Venereol. 2014 Nov;94(6):627-34. doi: 10.2340/00015555-1833.</mixed-citation><mixed-citation xml:lang="en">De Vlam K, Gottlieb AB, Mease PJ. Current concepts in psoriatic arthritis: pathogenesis and management. Acta Derm Venereol. 2014 Nov;94(6):627-34. doi: 10.2340/00015555-1833.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Van Mechelen M, Lories RJ. Microtrauma: no longer to be ignored in spondyloarthritis? Curr Opin Rheumatol. 2016 Mar;28(2):176-80. doi: 10.1097/BOR.0000000000000254.</mixed-citation><mixed-citation xml:lang="en">Van Mechelen M, Lories RJ. Microtrauma: no longer to be ignored in spondyloarthritis? Curr Opin Rheumatol. 2016 Mar;28(2):176-80. doi: 10.1097/BOR.0000000000000254.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pattison E, Harrison BJ, Griffiths CE, et al. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008 May;67(5):672-6. doi: 10.1136/ard.2007.073932.</mixed-citation><mixed-citation xml:lang="en">Pattison E, Harrison BJ, Griffiths CE, et al. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008 May;67(5):672-6. doi: 10.1136/ard.2007.073932.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Thumboo J, Uramoto K, Shbeeb MI, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002 Apr; 29(4):757-62.</mixed-citation><mixed-citation xml:lang="en">Thumboo J, Uramoto K, Shbeeb MI, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002 Apr; 29(4):757-62.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Eder L, Law T, Chandran V, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011 Aug; 63(8):1091-7. doi: 10.1002/acr.20496.</mixed-citation><mixed-citation xml:lang="en">Eder L, Law T, Chandran V, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011 Aug; 63(8):1091-7. doi: 10.1002/acr.20496.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz J, Evers AW, Bundy C, Kimball AB. Getting under the Skin: Report from the International Psoriasis Council Workshop on the Role of Stress in Psoriasis. Front Psychol. 2016 Feb 2;7:87. doi: 10.3389/fpsyg.2016.00087.eCollection2016.</mixed-citation><mixed-citation xml:lang="en">Schwartz J, Evers AW, Bundy C, Kimball AB. Getting under the Skin: Report from the International Psoriasis Council Workshop on the Role of Stress in Psoriasis. Front Psychol. 2016 Feb 2;7:87. doi: 10.3389/fpsyg.2016.00087.eCollection2016.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Trojacka E, Zaleska M, Galus R. Influence of exogenous and endogenous factors on the course of psoriasis. Pol Merkur Lekarski. 2015 Mar;38(225):169-73.</mixed-citation><mixed-citation xml:lang="en">Trojacka E, Zaleska M, Galus R. Influence of exogenous and endogenous factors on the course of psoriasis. Pol Merkur Lekarski. 2015 Mar;38(225):169-73.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Eder L, Haddad A, Rosen CF, et al. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study. Arthritis Rheumatol. 2016 Apr;68(4):915-23. doi: 10.1002/art.39494.</mixed-citation><mixed-citation xml:lang="en">Eder L, Haddad A, Rosen CF, et al. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study. Arthritis Rheumatol. 2016 Apr;68(4):915-23. doi: 10.1002/art.39494.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Stojanovich L. Stress and autoimmunity. Autoimmun Rev. 2010 Mar;9(5):A271-6. doi: 10.1016/j.autrev.2009.11.014.</mixed-citation><mixed-citation xml:lang="en">Stojanovich L. Stress and autoimmunity. Autoimmun Rev. 2010 Mar;9(5):A271-6. doi: 10.1016/j.autrev.2009.11.014.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Song H, Fang F, Tomasson G, et al. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA. 2018 Jun 19;319(23):2388-400. doi: 10.1001/ama.2018.7028.</mixed-citation><mixed-citation xml:lang="en">Song H, Fang F, Tomasson G, et al. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA. 2018 Jun 19;319(23):2388-400. doi: 10.1001/ama.2018.7028.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tasdelen OY, Yurdakul FG, Duran S, Bodur H. Isotretinoin-induced arthritis mimicking both rheumatoid arthritis and axial spondyloarthritis. Int J Rheum Dis. 2015 May; 18(4):466-9. doi: 10.1111/1756-185X.12464.</mixed-citation><mixed-citation xml:lang="en">Tasdelen OY, Yurdakul FG, Duran S, Bodur H. Isotretinoin-induced arthritis mimicking both rheumatoid arthritis and axial spondyloarthritis. Int J Rheum Dis. 2015 May; 18(4):466-9. doi: 10.1111/1756-185X.12464.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Elnady BD, Desouky D, Elkhouly T, et al. Isotretinoin induced seronegative spondyloarthropathy: magnetic resonance imaging as diagnostic and prognostic biomarker [abstract]. Arthritis Rheum. 2017;69(Suppl. 10):1569.</mixed-citation><mixed-citation xml:lang="en">Elnady BD, Desouky D, Elkhouly T, et al. Isotretinoin induced seronegative spondyloarthropathy: magnetic resonance imaging as diagnostic and prognostic biomarker [abstract]. Arthritis Rheum. 2017;69(Suppl. 10):1569.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Henning P, Conaway HH, Lerner UH. Retinoid receptors in bone and their role in bone remodeling. Front Endocrinol (Lausanne). 2015 Mar 11;6:31. doi: 10.3389/fendo.2015.00031.</mixed-citation><mixed-citation xml:lang="en">Henning P, Conaway HH, Lerner UH. Retinoid receptors in bone and their role in bone remodeling. Front Endocrinol (Lausanne). 2015 Mar 11;6:31. doi: 10.3389/fendo.2015.00031.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wu S, Han J, Qureshi AA. Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study. Acta Derm Venereol. 2015 Feb;95(2):217-23. doi: 10.2340/00015555-1855.</mixed-citation><mixed-citation xml:lang="en">Wu S, Han J, Qureshi AA. Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study. Acta Derm Venereol. 2015 Feb;95(2):217-23. doi: 10.2340/00015555-1855.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Li W, Han J, Choi HK, Qureshi AA. Smoking and Risk of Incident Psoriasis Among Women and Men in the United States: A Combined Analysis. Am J Epidemiol. 2012 Mar 1;175(5):402-13. doi: 10.1093/aje/kwr325. Epub 2012 Jan 12.</mixed-citation><mixed-citation xml:lang="en">Li W, Han J, Choi HK, Qureshi AA. Smoking and Risk of Incident Psoriasis Among Women and Men in the United States: A Combined Analysis. Am J Epidemiol. 2012 Mar 1;175(5):402-13. doi: 10.1093/aje/kwr325. Epub 2012 Jan 12.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hui M, Doherty M, Zhang W. Does smoking protect against osteoarthritis? Meta-analysis of observational studies. Ann Rheum Dis. 2011 Jul;70(7):1231-7. doi: 10.1136/ard.2010.142323.</mixed-citation><mixed-citation xml:lang="en">Hui M, Doherty M, Zhang W. Does smoking protect against osteoarthritis? Meta-analysis of observational studies. Ann Rheum Dis. 2011 Jul;70(7):1231-7. doi: 10.1136/ard.2010.142323.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Xie W, Huang H, Deng X, et al. Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2021 Mar;84(3):701-11. doi: 10.1016/j.jaad.2020.08.060.</mixed-citation><mixed-citation xml:lang="en">Xie W, Huang H, Deng X, et al. Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2021 Mar;84(3):701-11. doi: 10.1016/j.jaad.2020.08.060.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen UDT, Zhang Y, Lu N, et al. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018 Jan;77(1):119-23. doi: 10.1136/annrheumdis-2017-211625.</mixed-citation><mixed-citation xml:lang="en">Nguyen UDT, Zhang Y, Lu N, et al. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018 Jan;77(1):119-23. doi: 10.1136/annrheumdis-2017-211625.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012 Feb;71(2):219-24. doi: 10.1136/ard.2010.147793.</mixed-citation><mixed-citation xml:lang="en">Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012 Feb;71(2):219-24. doi: 10.1136/ard.2010.147793.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Green A, Shaddick G, Charlton R, et al; PROMPT study group. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis. Br J Dermatol. 2020 Mar;182(3):714-20. doi: 10.1111/bjd.18227.</mixed-citation><mixed-citation xml:lang="en">Green A, Shaddick G, Charlton R, et al; PROMPT study group. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis. Br J Dermatol. 2020 Mar;182(3):714-20. doi: 10.1111/bjd.18227.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Maciejewska-Radomska A, Szczerkowska-Dobosz A, Rebala K, et al. Frequency of streptococcal upper respiratory tract infections and HLA-Cw*06 allele in 70 patients with guttate psoriasis from northern Poland. Postepy Dermatol Alergol. 2015 Dec;32(6): 455-8. doi: 10.5114/pdia.2014.40982</mixed-citation><mixed-citation xml:lang="en">Maciejewska-Radomska A, Szczerkowska-Dobosz A, Rebala K, et al. Frequency of streptococcal upper respiratory tract infections and HLA-Cw*06 allele in 70 patients with guttate psoriasis from northern Poland. Postepy Dermatol Alergol. 2015 Dec;32(6): 455-8. doi: 10.5114/pdia.2014.40982</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
